TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
OCS

Oculis Holding AG

Healthcare · Biotechnology

7.50$ -1.4% vs. previous close Closing price · As of: Nov 12, 2026

Investor relations

Report Dates

Investor relations overview for Oculis Holding AG (OCS): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/09/2026.

Next report 11/09/2026
Last report 11/03/2026
Earnings surprise by quarter (%)
Q4 23 · 12.8 % 23 Q1 24 · -10.0 % 24 Q2 24 · -36.6 % 24 Q3 24 · -14.3 % 24 Q4 24 · -55.8 % 24 Q1 25 · -72.5 % 25 Q2 25 · -8.9 % 25 Q3 25 · 22.0 % 25 Q4 25 · -2.1 % 25 Q1 26 · -19.5 % 26 Q2 26 · 58.3 % 26 Q3 26 · 24.5 % 26

EPS estimate beaten

Full history 9 of 22 quarters (41%)
Last 16 quarters 4 of 16 quarters (25%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?